Executive officer

Adam S. Taich

Chief Financial Officer·10x Genomics, Inc.

About

Adam S. Taich has served as Chief Financial Officer of 10x Genomics since August 2024, also serving as Treasurer, principal financial officer and principal accounting officer.

He previously was Chief Strategy Officer of Standard BioTools from January 2024 to July 2024 and interim CEO of SomaLogic from March 2023 until its acquisition by Standard BioTools in January 2024, having also served as SomaLogic's Chief Business Officer and EVP of Life Sciences. Before that he spent 19 years at Thermo Fisher Scientific in roles including Vice President & General Manager-Molecular Biology and Vice President-Strategy and Business Development.

He holds a B.A. in Political Science and Russian from Miami University in Oxford, Ohio.

Since 2024
Age 51
Tenure 2 yrs

Also at 10x Genomics, Inc.

SS Serge Saxonov Chief Executive Officer and Director BH Benjamin J. Hindson Chief Scientific Officer, President and Director JS John R. Stuelpnagel Chairman of the Board of Directors AM Alan Mateo Director KP Kimberly J. Popovits Director ST Sarah Teichmann Director

Roles

Organization Role Dates Details
10x Genomics, Inc. Chief Financial Officer 2024–present Current role
Standard BioTools Inc. Chief Strategy Officer January 2024 - July 2024
SomaLogic, Inc. Interim Chief Executive Officer March 2023 - January 2024 Proteomics company; acquired by Standard BioTools in January 2024.
SomaLogic, Inc. Chief Business Officer November 2021 - March 2023
SomaLogic, Inc. Executive Vice President of Life Sciences April 2022 - March 2023
Thermo Fisher Scientific Vice President & General Manager-Molecular Biology February 2020 - June 2021 Part of 19 years at Thermo Fisher across various roles from 2004 to 2021.
Thermo Fisher Scientific Vice President-Strategy and Business Development April 2018 - February 2020
Thermo Fisher Scientific Vice President & General Manager-Protein and Cell Analysis October 2016 - April 2018
Thermo Fisher Scientific Vice President & General Manager-Global Services and Support November 2013 - October 2016

Related

Company 10x Genomics, Inc. Company hub Person Serge Saxonov Chief Executive Officer and Director Person Benjamin J. Hindson Chief Scientific Officer, President and Director Person John R. Stuelpnagel Chairman of the Board of Directors Person Alan Mateo Director Person Kimberly J. Popovits Director Person Sarah Teichmann Director Person Sri Kosaraju Director Person Shehnaaz Suliman Director Person Randy Wu General Counsel and Secretary Person Eric S. Whitaker Strategic Counsel (former Chief Legal Officer)
Source: 10x Genomics, Inc. proxy statement (SEC Schedule 14A)

Where the filing does not disclose a value, this page states "Not disclosed" rather than estimating. Smaller filers are exempt from disclosing metric targets and achievement, and larger filers may omit forward targets for competitive reasons.

See how VectorShift works for your firm

Request Demo